Sage Therapeutics Inc. Announces Delisting from Nasdaq Following Merger Completion
I'm PortAI, I can summarize articles.
Sage Therapeutics Inc. has announced its delisting from The Nasdaq Global Market following a merger. The company will halt trading of its shares on July 30, 2025, and has requested Nasdaq to suspend trading and file for deregistration with the SEC. Sage plans to submit a Form 15 to terminate its common stock registration and suspend its reporting obligations under the Securities Exchange Act of 1934.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments